Novus Therapeutics Inc

NASDAQ:NVUS  
25.41
+1.00 (+4.10%)
Earnings Announcements

Novus Therapeutics Reports Q3 2020 Financial Results

Published: 11/16/2020 22:22 GMT
Novus Therapeutics Inc (NVUS) - Novus Therapeutics Reports Third Quarter 2020 Financial Results.
Q3 Loss per Share $5.51.
Q3 Earnings per Share Estimate $-1.75 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$2.16

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$1.44

More details on our Analysts Page.